as on September 16, 2025 at 1:29 am IST
Day's Low
Day's High
1.69%
Downside
1.08%
Upside
52 Week's Low
52 Week's High
52.19%
Downside
10.95%
Upside
Check Rhythm Pharmaceuticals Inc market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.
Market Cap
$6.4B
EPS (TTM)
-2.951
Dividend Yield
0.00%
Quarterly Earnings Growth YOY
0.00%
PE Ratio (TTM)
-10.86
Industry PE ratio
10.127857142857144
P/B Ratio
0PEG Ratio
0EBITDA
-175.9M
Revenue (TTM)
156.3M
Profit Margin
-117.16%
Return On Equity TTM
12075100.00%
Track how Rhythm Pharmaceuticals Inc P/E has moved over time to understand its valuation trends.
Rhythm Pharmaceuticals Inc in the last 5 years
Lowest (0.00x)
September 15, 2025
Today (-10.86x)
September 15, 2025
Industry (10.13x)
September 15, 2025
Highest (0.00x)
September 15, 2025
Today’s Price to Earnings Ratio: -10.86x
Compare market cap, revenue, PE, and other key metrics of Rhythm Pharmaceuticals Inc with its industry peers.
Company | Analyst View | Market Cap | 5 Years Return % | PE Ratio | Profit Margin % |
---|---|---|---|---|---|
BUY | $6.4B | NA | -10.86 | -117.16% | |
BUY | $61.1B | 256.98% | -505.15 | -12.96% | |
NA | $38.7B | NA | NA | -3.89% | |
BUY | $101.1B | 47.85% | 28.07 | 31.86% | |
BUY | $59.4B | -3.43% | 14.11 | 31.37% |
The Rhythm Pharmaceuticals Inc stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.
*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.
Investment Value
₹1,00,000
Rhythm Pharmaceuticals Inc investment value today
Current value as on today
₹1,98,476
Returns
₹98,476
(+98.48%)
Returns from Rhythm Pharmaceuticals Inc Stock
₹93,491 (+93.49%)
Dollar Returns*
₹4,985 (+4.99%)
Based on 15 analysts
93.33%
Buy
6.67%
Hold
0.00%
Sell
Based on 15 analysts, 93.33% of analysts recommend a 'BUY' rating for Rhythm Pharmaceuticals Inc. Average target price of $112.5
Get share price movements and forecasts by analysts on Rhythm Pharmaceuticals Inc.
What analysts predicted
14.66%UPSIDE
Target Price
$112.5
Current Price
$96.01
Analyzed by
15 Analysts
Target
$112.50
Rhythm Pharmaceuticals Inc target price $112.5, a slight upside of 14.66% compared to current price of $96.01. According to 15 analysts rating.
Search interest for Rhythm Pharmaceuticals Inc Stock has decreased by -13% in the last 30 days, reflecting a downward trend in search activity.
Time period: to
All numbers in Millions USD
All numbers in Millions USD
All numbers in Millions USD
All numbers in Millions USD
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
Price Rise
In the last 3 months, RYTM stock has moved up by 53.0%
Profit Spike
Netprofit is up for the last 2 quarters, -49.49M → -46.63M (in $), with an average increase of 6.2% per quarter
Best in 3 Years
In the last 3 years, RYTM has outperformed top 5 stocks with highest market-cap in its industry
Best in 1 Year
In the last 1 year, RYTM has outperformed top 5 stocks with highest market-cap in its industry
Revenue Rich
Revenue is up for the last 2 quarters, 32.70M → 48.50M (in $), with an average increase of 32.6% per quarter
Organisation | Rhythm Pharmaceuticals Inc |
Headquarters | 222 Berkeley Street, Boston, MA, United States, 02116 |
Industry | Health Technology |
CEO | Dr. David P. Meeker M.D. |
E-voting on shares | Click here to vote |
Name | Title |
---|---|
Mr. David Connolly | Head of Investor Relations & Corporate Communications |
Dr. David P. Meeker M.D. | Chairman, President & CEO |
Mr. Hunter C. Smith M.B.A. | CFO & Treasurer |
Mr. Joseph Shulman | Chief Technical Officer |
Mr. Yann Mazabraud | Executive VP & Head of International |
Ms. Sarah Ryan | Vice President of Sales & Marketing |
Ms. Jennifer Lee | Executive VP & Head of North America |
Mr. Christopher P. German | Corporate Controller & Principal Accounting Officer |
Dr. Alastair Garfield Ph.D. | Chief Scientific Officer |
Mr. Jim Flaherty | Senior VP & General Counsel |
Rhythm Pharmaceuticals Inc share price today is $96.01 as on at the close of the market. Rhythm Pharmaceuticals Inc share today touched a day high of $97.05 and a low of $94.39.
Rhythm Pharmaceuticals Inc share touched a 52 week high of $106.52 on and a 52 week low of $45.91 on . Rhythm Pharmaceuticals Inc stock price today i.e. is closed at $96.01,which is 9.87% down from its 52 week high and 109.15% up from its 52 week low.
Rhythm Pharmaceuticals Inc market capitalisation is $0.01T as on .
Indian investors can start investing in Rhythm Pharmaceuticals Inc (RYTM) shares with as little as ₹88.141 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹881.41 in Rhythm Pharmaceuticals Inc stock (as per the Rupee-Dollar exchange rate as on ).
Based on Rhythm Pharmaceuticals Inc share’s latest price of $96.01 as on September 16, 2025 at 1:29 am IST, you will get 0.1042 shares of Rhythm Pharmaceuticals Inc. Learn more about
fractional shares .